20161 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to or , e.g. for obtaining a specific release pattern or for combining different drugs
Extended release liquid compositions of guanfacine
#302Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
#303Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
#304Fenofibrate formulation
#305Pharmaceutical composition containing clomipramine and preparation method therefor
#306Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
#307Nested particles and the use thereof for coordinated delvery of active agents
#308Abuse resistant pharmaceutical compositions
#309Extended release suspension compositions
#310Treating pain in patients with hepatic impairment
#311Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
#312Combination liposomal pharmaceutical formulations
#313Dosage forms for administering combinations of drugs
#314Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#315Pharmaceutical compositions for the treatment of
#316Benzonatate modified release solid tablets and capsules
#317Nicotine—diketopiperazine microparticle formulations and methods of making the same
#318Compositions for treatment of attention deficit hyperactivity disorder
#319Compositions and methods of using modified release solabegron for lower urinary tract symptoms
#320Methods and compositions particularly for treatment of attention deficit disorder
#321Timed, pulsatile release systems
#322DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#323Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto
#324Controlled release formulations of levodopa and uses thereof
#325Orally disintegrable tablet
#326Pulsed release phenylephrine dosage forms
#327Abuse resistant pharmaceutical compositions
#328Abuse resistant pharmaceutical compositions
#329Oral pharmaceutical dosage forms
#330Breathing control modulating compounds, and methods of using same
#331Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
#332Timed, pulsatile release systems
#333Tamper resistant pharmaceutical formulations
#334Sustained-release formulations of topiramate
#335POWDER FORMULATION COMPRISING THROMBIN AND FIBRINOGEN
#336Benzonatate modified release solid tablets and capsules
#337ORAL DELIVERY OF PROTEINS AND PEPTIDES
#338MULTIPARTICULATE PHARMACEUTICAL COMPOSITION COMPRISING A MULTITUDE OF TWO KINDS OF PELLETS
#339Delayed-release formulations, methods of making and use thereof
#340Pharmaceutical products
#341Treating pain in patients with hepatic impairment
#342Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#343Solid ganaxolone compositions and methods for the making and use thereof
#344Fixed dose combination therapy of Parkinson's disease
#345Core-shell particles, preparation process thereof, and composition containing the same
#346Disintegrating monolithic modified release tablets containing quadri-layer extended release granules
#347Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles
#348Multilayer compositions, coated devices and use thereof
#349Method of treatment of attention deficit hyperactivity disorder
#350Naloxone mono preparation and multilayer tablet
#351Pharmaceutical antiretroviral composition
#352Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
#353Multi-encapsulated formulations made with oxidized cellulose
#354System and method for multiphasic release of growth factors
#355Tamper-resistant oral opioid agonist formulations
#356Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
#357Sequential administration of partitioned absorption aspirin or active aspirin derivative and COX-2 inhibitor
#358Drug formulations having reduced abuse potential
#359Solid oral dosage form for breast symptoms
#360Pharmaceutical compositions for the coordinated delivery of NSAIDs
#361Modular nanodevices for smart adaptable vaccines
#362Fenofibrate formulation
#363Devices, formulations, and methods for delivery of multiple beneficial agents
#364Opioid agonist formulations with releasable and sequestered antagonist
#365Orally available pharmaceutical formulation suitable for improved management of movement disorders
#366ANTIRETROVIRAL COMPOSITION
#367FIXED DOSE COMBINATION THERAPY OF PARKINSON'S DISEASE
#368Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them
#369Concentrated, inhalable antibiotic formulation
#370Nitazoxadine composition and process to prepare same
#371Joint product comprising synephrine and topiramate
#372Treating pain in patients with hepatic impairment
#373Combination product comprising phentermine and topiramate, and preparation method thereof
#374Pharmaceutical compositions for the treatment of
#375Oral pharmaceutical compositions of dabigatran etexilate
#376Escalating dosing regimen for effecting weight loss and treating obesity
#377Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#378Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#379Delayed release cysteamine bead formulation, and methods of making and using same
#380Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#381Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#382Optimal colon targeting technology
#383Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
#384Delivery system for saw palmetto extract and carotenoid
#385Degradable removable implant for the sustained release of an active compound
#386Tamper resistant pharmaceutical formulations
#387Benzonatate modified release solid tablets and capsules
#388Tamper resistant dosage form comprising an adsorbent and an adverse agent
#389COMBINATION PRODUCTS
#390Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
#391Pharmaceutical compositions for the treatment of
#392Compositions for treatment of attention deficit hyperactivity disorder
#393Orally disintegrating tablet compositions of lamotrigine
#394Compositions for treatment of attention deficit hyperactivity disorder
#395Methods for treatment of attention deficit hyperactivity disorder
#396Escalating dosing regimen for effecting weight loss and treating obesity
#397Reduced dose pharmaceutical compositions of fenofibrate
#398Pharmaceutical composition
#399Solid ganaxolone compositions and methods for the making and use thereof
#400Pharmaceutical compositions for the coordinated delivery of NSAIDs
#401Pharmaceutical composition
#402Compositions comprising methylphenidate complexed with ion-exchange resin particles
#403System and method for multiphasic release of growth factors
#404Tamper-resistant oral opioid agonist formulations
#405CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#406Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#407Multi-encapsulated microspheres made with oxidized cellulose for in-situ reactions
#408Compositions and methods for treating respiratory disorders with doxofilline
#409Pharmaceutical Composition
#410Method and system using relays with aggregated spectrum
#411Compositions comprising methylphenidate complexed with ion-exchange resin particles
#412DOSAGE FORMS FOR ORAL ADMINISTRATION AND METHODS OF TREATMENT USING THE SAME
#413Controlled release formulations of levodopa and uses thereof
#414Controlled release formulations of levodopa and uses thereof
#415Oxidized cellulose miczrospheres including visualization agents
#416Gamma hydroxybutyric acid granules
#417Fenofibrate formulation
#418Method for encapsulating particles
#419Liquid ganaxolone formulations and methods for the making and use thereof
#420Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
#421Controlled release formulations of levodopa and uses thereof
#422Immunomodulatory compositions
#423Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles
#424Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles
#425COMBINATION COMPOSITION USEFUL FOR TREATING CARDIOVASCULAR DISEASES
#426Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
#427Methods and devices for providing prolonged drug therapy
#428Non-abusable pharmaceutical composition comprising opioids
#429pH-dependent gradual release pharmaceutical composition
#430Methods and devices for providing prolonged drug therapy
#431Modified release analgesic suspensions
#432Diversion-resistant microgranules and microtablets
#433Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
#434Orally disintegrating tablet compositions of lamotrigine
#435Stabilized topical formulations containing core-shell microcapsules
#436Devices, formulations, and methods for delivery of multiple beneficial agents
#437Sustained-Release Opioid Formulations and Methods of Use
#438CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION INCLUDING TAMSULOSIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND ORAL FORMULATION INCLUDING THE SAME
#439Abuse-deterrent pharmaceutical compositions of opiods and other drugs
#440Pharmaceutical composition comprising metformin and rosuvastatin
#441GASTRIC ACID SECRETION INHIBITING COMPOSITION
#442Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent
#443MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#444Method of treating malignant solid tumors using transcatheter arterial chemoembolization (TACE)
#445METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS
#446Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
#447Sustained-release formulations of topiramate
#448PHARMACEUTICAL COMPOSITION OF LANSOPRAZOLE
#449THERAPEUTIC REGIMENS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
#450COMPLEX FORMULATION COMPRISING ASPIRIN COATED WITH BARRIER CONTAINING HYDROPHOBIC ADDITIVE, AND HMG-COA REDUCTASE INHIBITOR
#451Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
#452NEW PHARMACEUTICAL DOSAGE FORM FOR THE TREATMENT OF GASTRIC ACID-RELATED DISORDERS
#453Opioid agonist formulations with releasable and sequestered antagonist
#454Tamper-resistant oral opioid agonist formulations
#455Degradable removable implant for the sustained release of an active compound
#456Pharmaceutical composition for treating parkinson's disease and preparation method thereof
#457Colon vitamin
#458CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#459Controlled release compositions of gamma-hydroxybutyrate
#460SUSTAINED RELEASE CANNABINOID MEDICAMENTS
#461DEXLANSOPRAZOLE COMPOSITIONS
#462Antibiotic product, use and formulation thereof
#463Dosage forms for tamper prone therapeutic agents
#464METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS
#465PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF OVERACTIVE BLADDER
#466MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#467Pharmaceutical compositions
#468Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia
#469COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#470Controlled release formulations of levodopa and uses thereof
#471STABLE COMBINATIONS OF AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
#472Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
#473DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME
#474CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#475Granulating process and thus prepared granulate
#476Timed, pulsatile release systems
#477Gastric Acid Secretion Inhibiting Composition
#478CONTROLLED RELEASE COMPOSITIONS COMPRISING A COMBINATION OF ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
#479ORAL MEDICINAL COMPOSITION AND ORAL MEDICINAL CAPSULE HAVING THE COMPOSITION ENCAPSULATED THEREIN
#480Extended release pharmaceutical compositions
#481Pharmaceutical compositions for the coordinated delivery of NSAIDs
#482PHARMACEUTICAL FORMULATIONS COMPRISING SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
#483Liquid ganaxolone formulations and methods for the making and use thereof
#484Reconstitutable microsphere compositions useful as ultrasonic contrast agents
#485FIXED DOSE DRUG COMBINATION FORMULATIONS
#486PARTICULATE PHARMACEUTICAL COMPOSITION WITH AN OPIOID AND AN OPIOID ANTAGONIST
#487Once a day amoxicillin product comprising immediate and delayed release dosage forms
#488Stable pharmaceutical composition for atherosclerosis
#489Combination Dosage Compositions Comprising a Cholesterol-Lowering Agent, a Renin-Angiotensin System Inhibitor, an Antioxidant Agent and an Antiplatelet Agent for Treatment and Prevention of Cardiovascular Disease
#490Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
#491NOVEL GASTRO-RETENTIVE DOSAGE FORMS
#492Once daily formulations of tetracyclines
#493Drug coating providing high drug loading and methods for providing the same
#494NSAID DOSE UNIT FORMULATIONS WITH H2-RECEPTOR ANTAGONISTS AND METHODS OF USE
#495METHODS AND MEDICAMENTS FOR ADMINISTRATION OF IBUPROFEN
#496METHODS AND MEDICAMENTS FOR ADMINISTRATION OF IBUPROFEN
#497PULSATILE RELEASE COMPOSITION OF THERAPEUTIC AGENT
#498Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
#499Once daily formulations of tetracyclines
#500PHARMACEUTICAL FORMULATIONS COMPRISING NSAID AND PROTON PUMP INHIBITOR DRUGS
#501METHOD OF TREATING CORONARY ARTERIES WITH PERIVASCULAR DELIVERY OF THERAPEUTIC AGENTS
#502Once daily formulations of tetracyclines
#503Sustained-release formulations of topiramate
#504Sustained-release formulations of topiramate
#505PHARMACEUTICAL COMPOSITIONS COMPRISING ROPINIROLE
#506MODIFIED GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR AMINE DRUGS
#507And potent tapentadol dosage forms
#508DUAL-RELEASE PHARMACEUTICAL SUSPENSION
#509Biodegradable Microspheres and Methods of Use Thereof
#510Opioid agonist formulations with releasable and sequestered antagonist
#511Solid pharmaceutical composition comprising amlodipine and losartan
#512SPACED DRUG DELIVERY SYSTEM
#513Compositions and methods for inhibiting gastric acid secretion
#514Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
#515Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
#516Pharmaceutical formulations
#517PULSED-RELEASE SILDENAFIL COMPOSITION AND METHOD FOR PREPARING SAID COMPOSITION
#518Solid ganaxolone formulations and methods for the making and use thereof
#519Dosage forms that facilitate rapid activation of barley protease zymogen
#520Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof
#521Pharmaceutical composition simultaneously having rapid-acting property and long-acting property
#522Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
#523Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
#524THERAPEUTIC REGIMENS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
#525Extended release composition containing tramadol
#526Low pH retinoid topical compositions
#527CONTROLLED RELEASE COMPOSITION
#528MULTIPARTICULATE TABLET AND METHOD FOR THE PRODUCTION THEREOF
#529Immediate release compositions of acid labile drugs
#530SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#531Extended release venlafaxine formulation
#532Modified release pharmaceutical compositions
#533Method and system using relays with aggregated spectrum
#534Concentrated, inhalable ciprofloxacin formulation
#535Implant devices that differ by release profile and methods of making and using same
#536EXTENDED-RELEASE DOSAGE FORM
#537PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER
#538MULTIPLE UNIT DOSAGE FORM OF NIACIN
#539COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#540Compositions and methods for inhibiting gastric acid secretion
#541PHARMACEUTICAL FORMULATION
#542Microcapsules having multiple shells and method for the preparation thereof
#543Granular compositions of magnesium oxide and citric acid and uses thereof
#544Pharmaceutical compositions of antiretrovirals
#545Gastric acid secretion inhibiting composition
#546Tamper-resistant oral opioid agonist formulations
#547Anti-misuse solid oral pharmaceutical form provided with a specific modified release profile
#548Benzonatate compositions and methods of use
#549COMBINATIONS OF NIACIN AND AN OXICAM
#550Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
#551Antifungal once-a-day product, use and formulation thereof
#552NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2
#553NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING CYCLOSPORINE
#554Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
#555Concentrated, inhalable antibiotic formulation
#556DRUG DELIVERY SYSTEM WITH STABILISING EFFECT
#557SUSTAINED RELEASE OF GUAIFENESIN
#558PHARMACEUTICAL COMPOSITION
#559PHARMACEUTICAL PREPARATION FOR TREATING CARDIOVASCULAR DISEASE
#560COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#561FORMULATIONS OF FLIBANSERIN
#562COMPOSITE PREPARATION
#563ORAL CONTROLLED RELEASE FORMULATIONS
#564Method of treating malignant solid tumors using transcatheter arterial chemoembolization (TACE)
#565Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds
#566Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
#567Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
#568Orally disintegrating solid preparation
#569Oral drug delivery system for azole, moxifloxacin and rifampicin
#570Orally disintegrating tablet compositions of lamotrigine
#571ORAL DELIVERY OF PROTEINS AND PEPTIDES
#572Controlled release formulations of levodopa and uses thereof
#573Antibiotic formulation and method of treatment
#574Ophthalmic Compositions with Hyaluronic Acid
#575TABLETS FOR COMBINATION THERAPY
#576Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells
#577PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN
#578Vaccination by transcutaneous targeting
#579SOLID PHARMACEUTICAL COMPOSITION COMPRISING 1-(4-CHLOROANILINO)-4-(4-PYRIDYLMETHYL)PHTHALAZINE AND A PH MODIFIER
#580Controlled release oral dosage form
#581Particles for delivery of nucleic acids and related devices and methods
#582Oral pharmaceutical dosage forms
#583Non-steroidal anti-inflammatory drug dosing regimen
#584PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE
#585Nanoparticulate and controlled release compositions comprising nilvadipine
#586PHARMACEUTICAL NIMODIPINE COMPOSITIONS
#587Oral Pharmaceutical Formulations Containing Non-Steroidal Anti-Inflammatory Drugs and Acid Inhibitors
#588O-DESMETHYLVENLAFAXINE AND BAZEDOXIFENE COMBINATION PRODUCT AND USES THEREOF
#589Abuse-Resistant Pharmaceutical Dosage Form
#590CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#591COMBINATION PHARMACEUTICAL COMPOSITIONS
#592GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS
#593Novel Pharmaceutical Modified Release Dosage Form Cyclooxygenase Enzyme Inhibitor
#594Pharmaceutical treatment process using chitosan or derivative thereof
#595OROS PUSH-STICK FOR CONTROLLED DELIVERY OF ACTIVE AGENTS
#596Compositions comprising carisoprodol and methods of use thereof
#597GASTROINTESTINAL-SPECIFIC MULTIPLE DRUG RELEASE SYSTEM
#598PROCESS FOR PREPARING PARTICLES OF OPIOIDS AND COMPOSITIONS PRODUCED THEREBY
#599METHODS OF TREATING CARDIOVASCULAR DISORDERS
#600HETEROGENEOUSLY CONFIGURED MULTIPARTICULATE GASTROINTESTINAL DRUG DELIVERY SYSTEM